Earnings Outlook For Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc. Class A AMRX | 12.32 12.32 | -0.24% 0.00% Post |
Amneal Pharmaceuticals (NASDAQ:AMRX) will release its quarterly earnings report on Friday, 2026-02-27. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Amneal Pharmaceuticals to report an earnings per share (EPS) of $0.18.
The announcement from Amneal Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Earnings Track Record
Last quarter the company beat EPS by $0.04, which was followed by a 8.2% increase in the share price the next day.
Here's a look at Amneal Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.13 | 0.17 | 0.15 | 0.15 |
| EPS Actual | 0.17 | 0.25 | 0.21 | 0.12 |
| Price Change % | 8.20 | -0.98 | 2.97 | 3.46 |
Amneal Pharmaceuticals Share Price Analysis
Shares of Amneal Pharmaceuticals were trading at $14.58 as of February 25. Over the last 52-week period, shares are up 68.17%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.